Khan, Kabir A.
Kerbel, Robert S.
Article History
First Online: 13 February 2018
Competing interests
: R.S.K. has sponsored research agreements with Boehringer Ingelheim, Neovacs, and Genentech. R.S.K. has received honoraria recently from Boehringer Ingelheim, NED Biosystems, Merck Pharmaceuticals, Apobiologix, and Onkaido and consultant fees for Neovacs. K.A.K. declares no competing interests.